TrialBlood advances2025
Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females.
Yohei Doi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
TrialBlood advances2025
Yohei Doi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.